ARCHIVES

Clinical Trials Approved By NCI’s CTEP Listed

This article is from The Cancer Letter archive.

Vol. 28 No. 2 | February 25, 2005

Download PDF Visit The Full Archive

Related Articles

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

November issue of Business & Regulatory Report, an additional 8 pages, included in this issue.

November 19, 2004

Protocols Approved During The Month of September 2001

October 26, 2001

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

New Research Training Act May Permit NCI To Help fill Clinical Gaps In Radiotherapy, Medical Oncology

July 26, 1974

With workload Up, Oncology Division To Add More Staff

August 2, 1996